---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-297177"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2025-11-25T23:59:59+00:00"
generated_at: "2026-05-16T16:53:58.866922+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Clearside Biomedical files for Chapter 11 bankruptcy; Nasdaq delisting effective Dec 1

## Summary
- Filed voluntary Chapter 11 petition on Nov 23, 2025 in Delaware (Case No. 25-12109).
- Nasdaq delisting notice received; trading suspended Dec 1, moving to OTC under symbol CLSDQ.
- Company intends to sell substantially all assets through a Section 363 auction.
- First-day motions filed to continue normal operations during the bankruptcy process.
- Assets include SCS Microinjector platform, CLS-AX program, and multiple licensing deals.

## SEC filing metadata
- accession: 0001193125-25-297177
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2025-11-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- confidence: high
- sec_items: 1.03, 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/0001193125-25-297177-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000119312525297177/d41251d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-297177
- JSON: https://secwatch.observer/filing/0001193125-25-297177.json
- Plain text: https://secwatch.observer/filing/0001193125-25-297177.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.